{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:25:31Z","timestamp":1787840731802,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB) pose significant global health challenges with high mortality risks. Adverse drug reactions (ADRs) further complicate treatment, impacting patient adherence and outcomes. In India, the DOTS strategy under the Revised National Tuberculosis Control Programme has been widely implemented, yet TB management is hindered by limited patient awareness, socioeconomic constraints, and gaps in healthcare provider training. This study assesses the incidence of ADRs and their impact on treatment outcomes at a tertiary care hospital in Delhi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted using retrospective medical record reviews of MDR-TB and XDR-TB patients (aged \u226518 years) registered at a university hospital in Delhi from January 2017 to August 2021. Data on ADRs and treatment outcomes were extracted from outpatient records for analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 213 enrolled patients, 183 were analyzed, with 72.6% experiencing at least one ADR. Males had a higher ADR incidence (58%) than females (42%). The most common ADRs were gastrointestinal disorders (21.8%), eye disorders (14.3%), and musculoskeletal disorders (14.3%), primarily linked to pyrazinamide, ethambutol, and ethionamide. Serious ADRs occurred in 17.4% of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Gastrointestinal disorders, particularly nausea and vomiting, emerged as the most commonly reported ADRs. These findings emphasize the importance of early identification of high-risk patients and the need for close monitoring throughout anti-TB treatment to support adherence and improve outcomes. This study adds valuable evidence to strengthen pharmacovigilance efforts and inform the optimization of MDR\/XDR-TB treatment protocols within India\u2019s public healthcare system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/picr.picr_70_25","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:00:33Z","timestamp":1761066033000},"page":"71-76","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of adverse drug reactions and treatment outcomes in drug-resistant tuberculosis: A retrospective study from a tertiary care hospital in Delhi"],"prefix":"10.4103","volume":"17","author":[{"given":"Amit","family":"Kamboj","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitij","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University College of Medical Sciences (University of Delhi) and Guru Teg Bahadur Hospital, Delhi, India"},{"name":"Department of Pulmonary and Critical Care Medicine, Delhi Hospital and Nursing Home, Rohtak Road, Bahadurgarh, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minakshi","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"R3-20260414","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.jiph.2023.10.009","article-title":"Prevalence and factors associated with tuberculosis infection in India","volume":"16","author":"Selvaraju","year":"2023","journal-title":"J Infect Public Health"},{"key":"R4-20260414","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2471\/BLT.13.129775","article-title":"Improving the estimation of the tuberculosis burden in India","volume":"92","author":"Cowling","year":"2014","journal-title":"Bull World Health Organ"},{"key":"R7-20260414","doi-asserted-by":"crossref","first-page":"e7482","DOI":"10.1097\/MD.0000000000007482","article-title":"Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: A retrospective study","volume":"96","author":"Yang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R12-20260414","doi-asserted-by":"crossref","first-page":"610","DOI":"10.55489\/njcm.140920233127","article-title":"Tuberculosis elimination: Implications and challenges","volume":"14","author":"Salama","year":"2023","journal-title":"Natl J Community Med"},{"key":"R13-20260414","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4103\/0970-2113.217569","article-title":"Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study","volume":"34","author":"Dela","year":"2017","journal-title":"Lung India"},{"key":"R14-20260414","first-page":"531","article-title":"Study of adverse drug reactions caused by first line anti-tubercular drugs used in directly observed treatment, short course (DOTS) therapy in Western Nepal, Pokhara","volume":"58","author":"Chhetri","year":"2008","journal-title":"J Pak Med Assoc"},{"key":"R16-20260414","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac512","article-title":"Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection","volume":"9","author":"Humayun","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 3","key":"R17-20260414","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/infdis\/jiu147","article-title":"Biological differences between the sexes and susceptibility to tuberculosis","volume":"209","author":"Nhamoyebonde","year":"2014","journal-title":"J Infect Dis"},{"key":"R18-20260414","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2050-6511-14-16","article-title":"Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal","volume":"14","author":"Santosh","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"R19-20260414","doi-asserted-by":"crossref","first-page":"684","DOI":"10.5694\/mja13.10069","article-title":"Low awareness of adverse drug reaction reporting systems: A consumer survey","volume":"199","author":"Robertson","year":"2013","journal-title":"Med J Aust"},{"key":"R20-20260414","first-page":"1373","article-title":"Side effects associated with the treatment of multidrug-resistant tuberculosis","volume":"9","author":"T\u00f6r\u00fcn","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"R21-20260414","first-page":"1314","article-title":"Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia","volume":"11","author":"Shin","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"R22-20260414","first-page":"275","article-title":"Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004","volume":"14","author":"Bloss","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"R23-20260414","doi-asserted-by":"crossref","first-page":"e0212948","DOI":"10.1371\/journal.pone.0212948","article-title":"Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy","volume":"14","author":"Gualano","year":"2019","journal-title":"PLoS One"},{"key":"R24-20260414","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4103\/lungindia.lungindia_118_19","article-title":"Ambispective study of adverse drug reactions in multi-drug resistant tuberculosis patients in Warangal, Telangana","volume":"38","author":"Fatima","year":"2021","journal-title":"Lung India"},{"key":"R25-20260414","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3126\/saarctb.v14i1.17718","article-title":"Side effects associated with drugs used in treatment of multi drug resistant tuberculosis and treatment related factors of multi drug resistant tuberculosis patients in Kathmandu Valley","volume":"14","author":"Bhatt","year":"2017","journal-title":"SAARC J Tuberc Lung Dis HIV AIDS"},{"key":"R26-20260414","doi-asserted-by":"crossref","first-page":"187","DOI":"10.18231\/j.ijooo.2020.042","article-title":"Ocular side effects of anti-tubercular drugs in patients receiving Anti-Tb treatment at tertiary care center","volume":"6","author":"Panchal","year":"2020","journal-title":"IP Int J Ocul Oncol Oculoplasty"},{"key":"R27-20260414","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1378\/chest.32.2.172","article-title":"Psychiatric and neurological reactions to cycloserine in the treatment of tuberculosis","volume":"32","author":"Lewis","year":"1957","journal-title":"Dis Chest"},{"key":"R28-20260414","first-page":"207","article-title":"Adverse reactions to drugs used in the treatment of tuberculosis","volume":"7","author":"Nariman","year":"1988","journal-title":"Adverse Drug React Acute Poisoning Rev"},{"key":"R29-20260414","doi-asserted-by":"crossref","first-page":"103","DOI":"10.21315\/mjms2018.25.5.10","article-title":"Evaluation of adverse reactions induced by anti-tuberculosis drugs in hospital Pulau Pinang","volume":"25","author":"Fei","year":"2018","journal-title":"Malays J Med Sci"}],"container-title":["Perspectives in Clinical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/picr.picr_70_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:27:52Z","timestamp":1787837272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/picr.picr_70_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/picr.picr_70_25","relation":{},"ISSN":["2229-3485","2229-5488"],"issn-type":[{"value":"2229-3485","type":"print"},{"value":"2229-5488","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"2025-04-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}